(redirected from unstable angina)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia.
References in periodicals archive ?
Develop business strategies by understanding the trends shaping and driving the global Unstable Angina Therapeutics market.
The presence of a high-risk lesion with acute characteristics on angiography was most strongly associated with a clinical presentation of unstable angina and with increased CRP (Table 3).
This evaluation was aimed at determining the clinical applicability of the AHCPR Unstable Angina guideline in a consecutive series of ED patients diagnosed with unstable angina and at projecting the potential effect of implementing the guideline on triage decisions.
White said the drug will save the lives of 13 of every 1,000 unstable angina patients treated.
2 Unstable Angina Therapeutics Market Forecast (2010-2018) - Global 18
We are very pleased the OASIS studies show that Refludan, already approved for treating heparin induced thrombocytopenia, holds promise for helping to increase the survival rates of patients with unstable angina," said Frank Douglas, M.
Lovenox/Clexane is the first antithrombotic agent that has been shown to be superior to unfractionated heparin, the current standard of care, in a major clinical study of unstable angina patients," said Marc Cohen, MD, director, Cardiovascular Diseases and Catheterization Laboratories, Allegheny University Hospitals, Hahnemann and MCP, and professor of medicine at Allegheny University of the Health Sciences in Philadelphia, Pennsylvania, USA.
Indications for use include stable or unstable angina, congestive heart failure, acute myocardial infarction and cardiogenic shock.
RPR is seeking marketing clearance for Lovenox to be administered with aspirin in the treatment of patients with unstable angina and non-Q-wave myocardial infarction.
March 17 /PRNewswire/ -- The investigational drug Aggrastat(R) (tirofiban) prevented the combination of heart attack, death and other cardiac complications by more than one-third in people suffering from unstable angina, in two landmark studies presented today at the 46th Annual Scientific Session of the American College of Cardiology (ACC).
EECP therapy is a noninvasive, outpatient therapy for the treatment of diseases of the cardiovascular system currently indicated for use in cases of stable or unstable angina, congestive heart failure, acute myocardial infarction and cardiogenic shock.
NYSE: RPR) announced today that the benefits of its low molecular weight heparin (LMWH), Lovenox(R) (enoxaparin sodium), are now being tested in patients with unstable angina in a new multi-center cardiology clinical trial known as the Thrombin Inhibition in Myocardial Infarction 11 (TIMI 11) study.